|Articles|April 5, 2011
ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin
Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
3
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
4
5 Notable FDA Approvals From the First Half of 2026
5